Our new Animal Health organization provides a product portfolio with breadth and depth unmatched in the industry. We now have a greater portfolio in key species areas, such as swine, cattle, and equine. This portfolio, combined with the skills and expertise of our field team, industry leading programs and services, our steadfast commitment to research and development, and our unwavering customer focus means Pfizer Animal Health Asia Pacific remains best poised to provide our customers with new and innovative animal health solutions on which they depend.
The integration offers unique opportunities for our customers especially in the fast growing poultry area, where we are combining a strong Fort Dodge biological business with the existing Pfizer poultry business as well as with the device business from our colleagues from Pfizer Poultry Health. Additionally there is an ideal complementary fit between our companies in Asia Pacific from a geographic perspective, which we will use to better serve our customers.
